Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 47

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 47
---
 a conversion value of approximately $2.6 million, convertible into shares of Common Stock at a conversion rate of the stated value thereof divided by a current effective conversion price of $100.00; (ii) 273 shares of Series B Preferred Stock with a conversion value of approximately $0.3 million, convertible into shares of Common Stock at a conversion rate of the stated value thereof divided by a current effective conversion price of approximately $3.072; (iii) 2,853 shares of Series C Preferred Stock with a stated value of approximately $2.9 million, convertible into shares of Common Stock at a conversion rate of the stated value thereof divided by a conversion price of $5.82; (iv) Series A Warrants to purchase 6,135 shares of Common Stock at an exercise price of $139.00 per share; (v) initial Series C Warrants to purchase 81,753 shares of Common Stock at an exercise price of $9.80; (vi) December 2024 and January 2025 Common Warrants to purchase an aggregate of 247,914 shares of Common Stock at an exercise price ranging from $5.61 to $5.82, and (vii) Public Warrants and Private Placement Warrants to purchase an aggregate of 95,186 shares of Common Stock at exercise prices ranging from $920.00 to $1,150.00 per share. Although each of the conversion price of the Preferred Shares and the exercise price of the Series A Preferred Warrants are at or above the trading price of our Common Stock as of the date of this prospectus, if such trading price increases, such conversion prices and exercise price will not change as a result thereof and could be below the trading price of our Common Stock as of the date of any future conversion or exercise thereof, resulting in dilution to our stockholders. In addition, the terms of the Series A Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock contain certain penalties and adjustments to the amount included in determination of the conversion rate following certain breaches of the Company’s obligations thereunder, including, among other things, as a result of a failure to file or cause the SEC to declare one or more registration statements relating to the resale of the shares of Common Stock issuable upon conversion thereof by specified deadlines, certain defaults under indebtedness of the Company or judgments against the Company and failure to deliver shares of Common Stock upon conversion in a timely manner. For example, the penalties and adjustments include a 25